In recent years, the field of DNA-modified cell therapies has experienced clinical advancements in patient outcomes specifically in late-stage cancer patients. Permanent changes to the genetic compositions in patients’ cells may lead to toxicities such as cytokine release syndrome, or the uncontrollable proliferation of DNA-modified cells. To address the irreversibility and lack of predictability of […]

DENVER — For the Davis family, moments looking through old photo albums not only provide a window into the past but also a future that couldn’t be. “We were just loving life. It was really, really good, and this has really clipped my wings” Paula Davis said. “It’s been difficult, life changing.” The Davis family […]

Athersys, Inc. is a US-based biotech company developing stem cell treatments for neurological, inflammatory and immune and cardiovascular diseases. Its patented MultiStem candidate can be delivered to patients up to 36 hours after ischemic stroke – significantly opening up the window to treatment. Dr Robert William Mays is Head of Neurosciences and Vice President of Regenerative Medicine […]